Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors
Disease area: Interstitial lung diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. van de Ven, S. Terheggen-Lagro, D. Hoytema van Konijnenburg, O. Kessels, P. de Jong, L. Sanders, J. van Montfrans (Utrecht, Netherlands). A HRCT score to differentiate between structural and interstitial lung disease in children with common variable immunodeficiency (CVID). Eur Respir J 2010; 36: Suppl. 54, 3472

Member's Comments

No comment yet.

Related content which might interest you: How could we objectively measure lung disease severity in children with severe combined immunodeficiency? Source: Annual Congress 2005 - New insights in respiratory infections in children Year: 2005 Pulmonary diseases in primary immunodeficiency syndromes Source: Respipedia Article Year: 2017 Granulomatosis-associated common variable immunodeficiency disorder: a case–control study versus sarcoidosis Source: Eur Respir J 2013; 41: 115-122 Year: 2013 Interstitial lung disease in common variable immunodeficiency associated granulomatous disease Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Comparison of health status in stable patients with bronchiectasis due to common variable immune deficiency (CVID), and idiopathic bronchiectasis Source: Annual Congress 2011 - Clinical parameters in airway diseases Year: 2011 A case of lymphoid interstitial pneumonia associated with common variable immunodeficiency Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Interstitial lung disease in CVID (GLILD): clinical presentation and comparison to CVID without ILD Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 The HRCT appearances of granulomatous pulmonary disease in common variable immune deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 489s Year: 2004 Predictive factors of idiopathic pulmonary fibrosis (IPF) in patients with a possible or inconsistent with usual interstitial pneumonia (UIP) pattern on high resolution computed tomography (HRCT) Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 High-resolution CT (HRCT) reflects disease progression in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017 Association between congenital pulmonary disease and primary immunodeficiency in the bronchiectasis patients Source: Eur Respir J 2005; 26: Suppl. 49, 376s Year: 2005 HRCT in the diagnosis of diffuse lung disease - overlap issues Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 Lung involvement in common variable immunodeficiency (CVID): a case series Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 High-resolution computed tomography and pulmonary function in children with common variable immunodeficiency Source: Eur Respir J 2011; 38: 1437-1443 Year: 2011 EBV and CMV as possible pathogens in patients presenting with interstitial lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 154s Year: 2006 Clinical and functional characteristics of patients with unclassifiable interstitial lung diseases (uILD) from eurIPFreg. Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Humoral immunodeficiency and the lung Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=220 Year: 2005 CT patterns of lung damage and prognosis markers for the course of a new coronavirus infection COVID-19 in persons with comorbidity Source: Virtual Congress 2021 – Biological and functional markers of COVID-19 Year: 2021 Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19. Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021 Pulmonary lymphoid hyperplasia (PLH) / lymphoid interstitial pneumonitis (LIP) complex in HIV-1 infected Brazilian children: associations and prognosis Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring Year: 2008